4//SEC Filing
Thompson David E. 4
Accession 0001104659-12-036053
CIK 0001316175other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 7:18 PM ET
Size
5.3 KB
Accession
0001104659-12-036053
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Award
Stock Option (right to buy)
2012-05-08+12,000→ 12,000 totalExercise: $1.79Exp: 2022-05-07→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of May 8, 2012. This stock option is fully exercisable on May 8, 2013.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001484500
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 7:18 PM ET
- Size
- 5.3 KB